Ahmad Shobrun Jamil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmad Shobrun Jamil has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Artabah Muchlisin
Universitas Muhammadiyah Malang
17 shared publications - Siti Rofida
Universitas Muhammadiyah Malang
4 shared publications - Irsan Fahmi Almuhtarihan
Universitas Muhammadiyah Malang
3 shared publications Azka Khoirunnisa
Program Studi Farmasi, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Malang
2 shared publicationsDwi Hanif Muluqul Fath
Program Studi Farmasi, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Malang
2 shared publicationsAgustin Rafikayanti
Universitas Muhammadiyah Malang
1 shared publication
Latest Publications
- 15 March 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (2) , 367-380
Exploring the Potential of Skeletonema costatum, natural shrimp feed as an Antihyperglycemic and Antihypercholesterolemic Therapy for Diabetes Mellitus in Mice
This study explores the antihyperglycemic and antihypercholesterolemic potential of Skeletonema costatum, a marine microalga, in diabetic and hypercholesterolemic mice models. The study compared the effects of S. costatum in infusion (SCI) and powder (SCP) forms at two concentrations (2.5% and 5%) with standard treatments, including glibenclamide for diabetes and simvastatin for hypercholesterolemia, as well as a no-treatment control. Over 21 days, SCP demonstrated significant and sustained reductions in both blood glucose and cholesterol levels, with the 2.5% SCP dose outperforming the 5% dose. SCI showed transient effects, with initial reductions in glucose and cholesterol levels followed by rebounds, likely due to the rapid metabolism of bioactive compounds. The powdered form's superior efficacy is attributed to its slower digestion and gradual release of omega-3 fatty acids, polyphenols, and bioactive peptides, which improve insulin sensitivity, reduce oxidative stress, and regulate lipid metabolism. Simvastatin showed the most pronounced cholesterol-lowering effect, confirming its efficacy as a standard therapy. The study underscores the potential of S. costatum, particularly SCP, as a natural alternative or complementary therapy for managing diabetes and hypercholesterolemia. Future investigations should optimize dosing, explore its synergistic effects with conventional treatments, and evaluate its long-term safety and therapeutic potential in humans.
- 15 March 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (2) , 367-380
Exploring the Potential of Skeletonema costatum, natural shrimp feed as an Antihyperglycemic and Antihypercholesterolemic Therapy for Diabetes Mellitus in Mice
This study explores the antihyperglycemic and antihypercholesterolemic potential of Skeletonema costatum, a marine microalga, in diabetic and hypercholesterolemic mice models. The study compared the effects of S. costatum in infusion (SCI) and powder (SCP) forms at two concentrations (2.5% and 5%) with standard treatments, including glibenclamide for diabetes and simvastatin for hypercholesterolemia, as well as a no-treatment control. Over 21 days, SCP demonstrated significant and sustained reductions in both blood glucose and cholesterol levels, with the 2.5% SCP dose outperforming the 5% dose. SCI showed transient effects, with initial reductions in glucose and cholesterol levels followed by rebounds, likely due to the rapid metabolism of bioactive compounds. The powdered form's superior efficacy is attributed to its slower digestion and gradual release of omega-3 fatty acids, polyphenols, and bioactive peptides, which improve insulin sensitivity, reduce oxidative stress, and regulate lipid metabolism. Simvastatin showed the most pronounced cholesterol-lowering effect, confirming its efficacy as a standard therapy. The study underscores the potential of S. costatum, particularly SCP, as a natural alternative or complementary therapy for managing diabetes and hypercholesterolemia. Future investigations should optimize dosing, explore its synergistic effects with conventional treatments, and evaluate its long-term safety and therapeutic potential in humans.
- Open Access
- 13 February 2025
- Published by Slovak University of Agriculture in Nitra in Journal of microbiology, biotechnology and food sciences
- Vol. 14 (5) , e10992
EVALUATION OF T LYMPHOCYTE AND REGULATORY T CELL EXPRESSION IN WISTAR RAT POST 90 DAYS OF CHERAL® ADMINISTRATION ORALLY
This study aimed to assess the impact of administering Cheral® (Curcuma longa and Phyllanthus niruri) on the expression of T lymphocytes and regulatory T cells. The research was conducted in vivo using 24 healthy female Wistar rats, which were categorized into four treatment groups: normal (control), dose 1 (156.25 mg/Kg BW), dose 2 (312.5 mg/Kg BW), and dose 3 (468.75 mg/Kg BW). The rats were orally administered Cheral® for a period of 90 days. T lymphocytes and regulatory T cell profiles were analyzed using flow cytometry. The data obtained were subsequently subjected to analysis using SPSS software with One-way ANOVA and Post hoc tests (p-value <0.05). The profiles of T lymphocytes and regulatory T cells following Cheral® administration exhibited diverse outcomes when compared to the normal group. Specifically, dose 2 led to a significant increase in CD4, while dose 1 resulted in a significant increase in CD8. However, the profile of regulatory T cells after Cheral® administration did not exhibit any significant differences when compared to the control group. In conclusion, this research indicates that the compounds present in Cheral® have the potential to modulate the immune system through their effects on T lymphocytes and regulatory T cells.
- 13 February 2025
- Published by Slovak University of Agriculture in Nitra in Journal of microbiology, biotechnology and food sciences
- Vol. 14 (5) , e10992
Open AccessEVALUATION OF T LYMPHOCYTE AND REGULATORY T CELL EXPRESSION IN WISTAR RAT POST 90 DAYS OF CHERAL® ADMINISTRATION ORALLY
This study aimed to assess the impact of administering Cheral® (Curcuma longa and Phyllanthus niruri) on the expression of T lymphocytes and regulatory T cells. The research was conducted in vivo using 24 healthy female Wistar rats, which were categorized into four treatment groups: normal (control), dose 1 (156.25 mg/Kg BW), dose 2 (312.5 mg/Kg BW), and dose 3 (468.75 mg/Kg BW). The rats were orally administered Cheral® for a period of 90 days. T lymphocytes and regulatory T cell profiles were analyzed using flow cytometry. The data obtained were subsequently subjected to analysis using SPSS software with One-way ANOVA and Post hoc tests (p-value <0.05). The profiles of T lymphocytes and regulatory T cells following Cheral® administration exhibited diverse outcomes when compared to the normal group. Specifically, dose 2 led to a significant increase in CD4, while dose 1 resulted in a significant increase in CD8. However, the profile of regulatory T cells after Cheral® administration did not exhibit any significant differences when compared to the control group. In conclusion, this research indicates that the compounds present in Cheral® have the potential to modulate the immune system through their effects on T lymphocytes and regulatory T cells.
- Open Access
- 30 August 2024
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 7 (3) , 233-246
Integrative Network Pharmacology Unveils Limonia acidissima as a Potential Natural Product for Targeting Cancer
Cancer remains a formidable health challenge worldwide, with complex molecular mechanisms driving its initiation, progression, and therapeutic resistance. In this study, we employed bioinformatics analyses to elucidate the molecular underpinnings of cancer biology, focusing on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Our GO analysis revealed the enrichment of key biological processes such as protein phosphorylation, regulation of programmed cell death, and transmembrane receptor signaling pathways, underscoring the critical roles of signaling cascades and regulatory mechanisms in tumorigenesis. Similarly, molecular functions such as protein kinase activity and ATP binding were identified as significantly enriched, highlighting the importance of protein kinases and molecular interactions in cancer development and progression. The KEGG pathway analysis further delineated dysregulated signaling pathways associated with cancer, including the MAPK and PI3K-Akt signaling pathways, implicating these pathways as central regulators of cancer progression. These findings deepen our understanding of cancer biology and offer potential targets for therapeutic intervention. Integrating multi-omics data and systems biology approaches may provide deeper insights into the intricate networks underlying cancer pathogenesis, paving the way for developing more effective treatments for cancer patients.
- 30 August 2024
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 7 (3) , 233-246
Open AccessIntegrative Network Pharmacology Unveils Limonia acidissima as a Potential Natural Product for Targeting Cancer
Cancer remains a formidable health challenge worldwide, with complex molecular mechanisms driving its initiation, progression, and therapeutic resistance. In this study, we employed bioinformatics analyses to elucidate the molecular underpinnings of cancer biology, focusing on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Our GO analysis revealed the enrichment of key biological processes such as protein phosphorylation, regulation of programmed cell death, and transmembrane receptor signaling pathways, underscoring the critical roles of signaling cascades and regulatory mechanisms in tumorigenesis. Similarly, molecular functions such as protein kinase activity and ATP binding were identified as significantly enriched, highlighting the importance of protein kinases and molecular interactions in cancer development and progression. The KEGG pathway analysis further delineated dysregulated signaling pathways associated with cancer, including the MAPK and PI3K-Akt signaling pathways, implicating these pathways as central regulators of cancer progression. These findings deepen our understanding of cancer biology and offer potential targets for therapeutic intervention. Integrating multi-omics data and systems biology approaches may provide deeper insights into the intricate networks underlying cancer pathogenesis, paving the way for developing more effective treatments for cancer patients.
- Open Access
- 30 June 2024
- Published by Maulana Malik Ibrahim State Islamic University in Journal of Islamic Pharmacy
- Vol. 9 (1) , 43-49
Analisis Network Pharmacology Senyawa Metabolit Sekunder Tanaman Lengkuas (Alpinia galanga) pada Penyakit Kanker
Analisis Network Pharmacology Senyawa Metabolit Sekunder Tanaman Lengkuas (Alpinia galanga) pada Penyakit Kanker
- 30 June 2024
- Published by Maulana Malik Ibrahim State Islamic University in Journal of Islamic Pharmacy
- Vol. 9 (1) , 43-49
Open AccessAnalisis Network Pharmacology Senyawa Metabolit Sekunder Tanaman Lengkuas (Alpinia galanga) pada Penyakit Kanker
Analisis Network Pharmacology Senyawa Metabolit Sekunder Tanaman Lengkuas (Alpinia galanga) pada Penyakit Kanker
- Open Access
- 10 June 2024
- Published by Universitas Gadjah Mada in Majalah Farmaseutik
- Vol. 20 (2) , 282-291
Network Pharmacology Analysis of Secondary Metabolites of Ciplukan (Physalis angulata L.) Against Lung Cancer
Lung cancer is the most common and high-risk type of cancer. Ciplukan (Physalis angulata L.) has antibacterial, anti-inflammatory, and anticancer activities, as well as cytotoxic ability and inhibits cancer cell growth. Research that discusses the molecular cellular mechanism of P. angulata's potential as an anti-lung cancer has not been widely informed, especially on the network pharmacology aspect of this plant's active compounds. This study reveals the prediction of the molecular mechanism of active compounds of P. angulata as anti-lung cancer using several tools including: Compound database retrieval with Knapsack and PubChem. Absorption Distribution Metabolism and Excretion (ADME) screening with SwissADME. Target protein identification with Gene Card, SwissTargetPrediction and Venny Diagram. Network pharmacology construction with String-DB and Cytoscape. Network pharmacology analysis using Gene Ontology (GO), and Cellular Component and Molecular Function. Based on the results of the analysis of P. angulata protein potential based on Maximal Clique Centrality (MCC) on CytoHubba in Cytoscape application, it shows that the Protein-protein Interaction (PPI) network has 10 main targets, namely ERBB2, KRAS, TP53, PTEN, CDKN2A, NRAS, PIK3CA, BRAF, NF1, and EGFR which interact with each other to regulate cell growth, differentiation, and survival. The results of this study can be concluded that the secondary metabolite compounds of P. angulata have the potential to control and alternative for lung cancer therapy.
- 10 June 2024
- Published by Universitas Gadjah Mada in Majalah Farmaseutik
- Vol. 20 (2) , 282-291
Open AccessNetwork Pharmacology Analysis of Secondary Metabolites of Ciplukan (Physalis angulata L.) Against Lung Cancer
Lung cancer is the most common and high-risk type of cancer. Ciplukan (Physalis angulata L.) has antibacterial, anti-inflammatory, and anticancer activities, as well as cytotoxic ability and inhibits cancer cell growth. Research that discusses the molecular cellular mechanism of P. angulata's potential as an anti-lung cancer has not been widely informed, especially on the network pharmacology aspect of this plant's active compounds. This study reveals the prediction of the molecular mechanism of active compounds of P. angulata as anti-lung cancer using several tools including: Compound database retrieval with Knapsack and PubChem. Absorption Distribution Metabolism and Excretion (ADME) screening with SwissADME. Target protein identification with Gene Card, SwissTargetPrediction and Venny Diagram. Network pharmacology construction with String-DB and Cytoscape. Network pharmacology analysis using Gene Ontology (GO), and Cellular Component and Molecular Function. Based on the results of the analysis of P. angulata protein potential based on Maximal Clique Centrality (MCC) on CytoHubba in Cytoscape application, it shows that the Protein-protein Interaction (PPI) network has 10 main targets, namely ERBB2, KRAS, TP53, PTEN, CDKN2A, NRAS, PIK3CA, BRAF, NF1, and EGFR which interact with each other to regulate cell growth, differentiation, and survival. The results of this study can be concluded that the secondary metabolite compounds of P. angulata have the potential to control and alternative for lung cancer therapy.
- Open Access
- 30 May 2024
- Published by Universitas Buana Perjuangan Karawang in Pharma Xplore : Jurnal Sains dan Ilmu Farmasi
- Vol. 9 (1) , 23-35
ANALISIS POTENSIAL Alpinia galanga MENGGUNAKAN JEJARING FARMAKOLOGI MELALUI ANALISIS PENGAYAAN GENE ONTOLOGY DAN KEGG (KYTO ENCYCLOPEDIA OF GENE AND GENOMES) SEBAGAI ANTIDIABETES
Alpinia galanga L., is a family of Zingiberaceae that has been used traditionally in various medicinal practices due to its therapeutic properties. With this, this research aims to identify the potential content of Alpinia galanga metabolite compounds as one of the potential alternative therapies in cases of diabetes mellitus and several other disorders. In this study, in silico methods were used, namely pharmacological networks and also Gene Ontology and KEEG pathway enrichment analysis which revealed 28 metabolite compounds that have links to plants and diseases to be studied and also revealed the enrichment of key molecular functions such as catalytic activity, protein kinase activity, and small molecule binding, indicating their regulatory and catalytic properties. In addition, KEGG (Kyto Encyclopedia of Genes and Genomes) pathway analysis highlighted its involvement in signaling pathways associated with glucose homeostasis, cancer, and hormone response. Examination of cellular component terms revealed the subcellular localization and potential interactions of A. galanga compounds in cellular compartments such as the cytoplasm, plasma membrane, and cell periphery. The results showed that out of 28 metabolite compounds, 1 metabolite compounds in A. galanga, namely 1'S-1'- acetosxychavicol, have the potential for treatment in diabetes mellitus cases and show the diverse pharmacological properties of A. galanga, which has implications for its potential in the development of new therapies targeting various diseases and disorders. Alpinia galanga L., merupakan famili Zingiberaceae yang telah digunakan secara tradisional dalam berbagai praktik pengobatan karena sifat terapeutiknya. Dengan hal tersebut penelitiaan ini bertujuan untuk mengidentifikasi kadungan potensial senyawa metabolit Alpinia galanga sebagai salah satu potensi terapi alternatif pada kasus diabetes melitus dan beberapa penyakit gangguan lainnya. Dalam penelitian ini, metode in silico yaitu jejaring farmakologi dan juga analisis pengayaan Gene Ontology dan KEEG pathway yang mengungkapkan terdapat 28 senyawa metabolit yang memiliki keterkaitan pada tanaman dan penyakit yang akan diteliti dan juga menggungkapkan pengayaan fungsi molekuler utama seperti aktivitas katalitik, aktivitas protein kinase, dan pengikatan molekul kecil, yang mengindikasikan sifat pengaturan dan katalitiknya. Selain itu, analisis jalur KEGG (Kyto Encyclopedia of Gene and Genomes) menyoroti keterlibatannya dalam jalur pensinyalan yang terkait dengan homeostasis glukosa, kanker, dan respons hormon. Pemeriksaan istilah komponen seluler mengungkap lokalisasi subseluler dan interaksi potensial senyawa A. galanga dalam kompartemen seluler seperti sitoplasma, membran plasma, dan pinggiran sel. Hasil penelitian menunjukkan bahwa senyawa metabolit dari 28 senyawa metabolit yaitu terdapat 1 senyawa metabolit pada A.galanga yaitu dan 1’S-1’- asetosksikavikol berpotensi pada pengobatan pada kasus diabetes mellitus dan menunjukkan sifat farmakologis A. galanga yang beragam, yang berimplikasi pada potensinya dalam pengembangan terapi baru yang menargetkan berbagai penyakit dan gangguan.
- 30 May 2024
- Published by Universitas Buana Perjuangan Karawang in Pharma Xplore : Jurnal Sains dan Ilmu Farmasi
- Vol. 9 (1) , 23-35
Open AccessANALISIS POTENSIAL Alpinia galanga MENGGUNAKAN JEJARING FARMAKOLOGI MELALUI ANALISIS PENGAYAAN GENE ONTOLOGY DAN KEGG (KYTO ENCYCLOPEDIA OF GENE AND GENOMES) SEBAGAI ANTIDIABETES
Alpinia galanga L., is a family of Zingiberaceae that has been used traditionally in various medicinal practices due to its therapeutic properties. With this, this research aims to identify the potential content of Alpinia galanga metabolite compounds as one of the potential alternative therapies in cases of diabetes mellitus and several other disorders. In this study, in silico methods were used, namely pharmacological networks and also Gene Ontology and KEEG pathway enrichment analysis which revealed 28 metabolite compounds that have links to plants and diseases to be studied and also revealed the enrichment of key molecular functions such as catalytic activity, protein kinase activity, and small molecule binding, indicating their regulatory and catalytic properties. In addition, KEGG (Kyto Encyclopedia of Genes and Genomes) pathway analysis highlighted its involvement in signaling pathways associated with glucose homeostasis, cancer, and hormone response. Examination of cellular component terms revealed the subcellular localization and potential interactions of A. galanga compounds in cellular compartments such as the cytoplasm, plasma membrane, and cell periphery. The results showed that out of 28 metabolite compounds, 1 metabolite compounds in A. galanga, namely 1'S-1'- acetosxychavicol, have the potential for treatment in diabetes mellitus cases and show the diverse pharmacological properties of A. galanga, which has implications for its potential in the development of new therapies targeting various diseases and disorders. Alpinia galanga L., merupakan famili Zingiberaceae yang telah digunakan secara tradisional dalam berbagai praktik pengobatan karena sifat terapeutiknya. Dengan hal tersebut penelitiaan ini bertujuan untuk mengidentifikasi kadungan potensial senyawa metabolit Alpinia galanga sebagai salah satu potensi terapi alternatif pada kasus diabetes melitus dan beberapa penyakit gangguan lainnya. Dalam penelitian ini, metode in silico yaitu jejaring farmakologi dan juga analisis pengayaan Gene Ontology dan KEEG pathway yang mengungkapkan terdapat 28 senyawa metabolit yang memiliki keterkaitan pada tanaman dan penyakit yang akan diteliti dan juga menggungkapkan pengayaan fungsi molekuler utama seperti aktivitas katalitik, aktivitas protein kinase, dan pengikatan molekul kecil, yang mengindikasikan sifat pengaturan dan katalitiknya. Selain itu, analisis jalur KEGG (Kyto Encyclopedia of Gene and Genomes) menyoroti keterlibatannya dalam jalur pensinyalan yang terkait dengan homeostasis glukosa, kanker, dan respons hormon. Pemeriksaan istilah komponen seluler mengungkap lokalisasi subseluler dan interaksi potensial senyawa A. galanga dalam kompartemen seluler seperti sitoplasma, membran plasma, dan pinggiran sel. Hasil penelitian menunjukkan bahwa senyawa metabolit dari 28 senyawa metabolit yaitu terdapat 1 senyawa metabolit pada A.galanga yaitu dan 1’S-1’- asetosksikavikol berpotensi pada pengobatan pada kasus diabetes mellitus dan menunjukkan sifat farmakologis A. galanga yang beragam, yang berimplikasi pada potensinya dalam pengembangan terapi baru yang menargetkan berbagai penyakit dan gangguan.
- 5 May 2024
- Published by Inkes Deli Husada Deli Tua in Jurnal Penelitian Farmasi & Herbal
- Vol. 6 (2) , 15-22
ANALISIS KETERKAITAN NETWORK PHAMACOLOGY SENYAWA METABOLIT SEKUNDER Abrus precatorius L. SECARA IN SILICO
Cancer remains a global health challenge, prompting extensive research efforts worldwide. Lung cancer, the second most diagnosed cancer, presents a particularly grim survival rate. In Indonesia, cancer incidence ranks significantly, with millions affected and hundreds of thousands succumbing to the disease annually. Traditional medicine persists as a preferred option among many, perceived as safer and more affordable. Abrus precatorius L., an ancient medicinal plant, holds promise in this regard, with a rich history of use and a diverse range of pharmacological activities, including anti-cancer properties. Employing in silico modeling and network pharmacology, this study explores the interaction between Abrus precatorius L. compounds and various proteins associated with cancer. Through bioinformatics tools and databases, 27 bioactive compounds are identified and their physicochemical properties assessed, ensuring adherence to pharmacological guidelines. The study predicts potential protein targets for Abrus precatorius L. compounds, revealing interactions with 453 proteins, including those implicated in cancer pathways. Further analysis using StringDB and DISEASES database establishes protein-protein interaction networks, highlighting key proteins like EGFR and TERT, pivotal in multiple cancer types. The study validates the compounds' adherence to Lipinski's Rule of Five, indicating their potential for pharmacological activity and oral absorption. False Discovery Rate (FDR) analysis confirms significant associations between Abrus precatorius L. compounds and various cancers, further underscoring their therapeutic potential. In conclusion, Abrus precatorius L. compounds, particularly targeting EGFR and TERT proteins, emerge as promising candidates for cancer treatment. Their diverse pharmacological activities and interactions with key cancer-related proteins pave the way for further exploration and development of these compounds as alternative medicinal agents. In vitro and in vivo studies are warranted to validate their efficacy, particularly in addressing the complexities of different cancer types. Ultimately, this research offers valuable insights into leveraging natural compounds for combating cancer, addressing a critical need in global healthcare.
- 5 May 2024
- Published by Inkes Deli Husada Deli Tua in Jurnal Penelitian Farmasi & Herbal
- Vol. 6 (2) , 15-22
ANALISIS KETERKAITAN NETWORK PHAMACOLOGY SENYAWA METABOLIT SEKUNDER Abrus precatorius L. SECARA IN SILICO
Cancer remains a global health challenge, prompting extensive research efforts worldwide. Lung cancer, the second most diagnosed cancer, presents a particularly grim survival rate. In Indonesia, cancer incidence ranks significantly, with millions affected and hundreds of thousands succumbing to the disease annually. Traditional medicine persists as a preferred option among many, perceived as safer and more affordable. Abrus precatorius L., an ancient medicinal plant, holds promise in this regard, with a rich history of use and a diverse range of pharmacological activities, including anti-cancer properties. Employing in silico modeling and network pharmacology, this study explores the interaction between Abrus precatorius L. compounds and various proteins associated with cancer. Through bioinformatics tools and databases, 27 bioactive compounds are identified and their physicochemical properties assessed, ensuring adherence to pharmacological guidelines. The study predicts potential protein targets for Abrus precatorius L. compounds, revealing interactions with 453 proteins, including those implicated in cancer pathways. Further analysis using StringDB and DISEASES database establishes protein-protein interaction networks, highlighting key proteins like EGFR and TERT, pivotal in multiple cancer types. The study validates the compounds' adherence to Lipinski's Rule of Five, indicating their potential for pharmacological activity and oral absorption. False Discovery Rate (FDR) analysis confirms significant associations between Abrus precatorius L. compounds and various cancers, further underscoring their therapeutic potential. In conclusion, Abrus precatorius L. compounds, particularly targeting EGFR and TERT proteins, emerge as promising candidates for cancer treatment. Their diverse pharmacological activities and interactions with key cancer-related proteins pave the way for further exploration and development of these compounds as alternative medicinal agents. In vitro and in vivo studies are warranted to validate their efficacy, particularly in addressing the complexities of different cancer types. Ultimately, this research offers valuable insights into leveraging natural compounds for combating cancer, addressing a critical need in global healthcare.
- Open Access
- 13 November 2023
- Published by Maulana Malik Ibrahim State Islamic University in Proceedings of International Pharmacy Ulul Albab Conference and Seminar (planar)
- Vol. 3, 28-36
A Network Pharmacology of Brotowali (Tinospora cordifolia) on Immunity Cases
COVID-19 is a disease outbreak related to the human immune system. The process of spreading very quickly makes this outbreak a dangerous pandemic. COVID-19 cases in 2020 in Indonesia, positive cases were reaching 1,089,308 people with a death rate of 20,277 people as of 2 February 2021. Efforts are being made to reduce and prevent virus transmission by boosting the immune system using an immunomodulator. Based on the literature studies that have been conducted, several Indonesian local plants have potential as immunomodulator. The in silico test was carried out because the computer simulation method has scientific validity, is relatively new, and has a high level of accuracy. This study aims to determine the protein network associated with the body's immune system, which is activated due to the administration of Brotowali (Tinospora Cordifolia). The research method used is exploratory descriptive with in silico analysis using a computational model with online databases, including KNApSAck, Dr. Duke, Pubchem, SwissADME, SwissTargetPrediction, Venny, StringDB, and KEGG. Based on the results of pharmacological network analysis, T. Cordifolia contains 33 secondary metabolites, 25 of which have high bioavailability. Proteins associated with T. cordifolia contain 640 compounds, and those related to immunomodulators contain 1380 proteins. The intersection results obtained 191 proteins predicted to interact with T. cordifolia and are related to immunomodulators. Based on KEGG Pathway analysis, there are five critical pathways in the immunomodulatory system, namely Th17 cell differentiation, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, and TNF signaling pathway. 1-hydroxy-2-methyl-anthraquinone can be an immunomodulator because it interacts with five critical pathways in the immunomodulator system.
- 13 November 2023
- Published by Maulana Malik Ibrahim State Islamic University in Proceedings of International Pharmacy Ulul Albab Conference and Seminar (planar)
- Vol. 3, 28-36
Open AccessA Network Pharmacology of Brotowali (Tinospora cordifolia) on Immunity Cases
COVID-19 is a disease outbreak related to the human immune system. The process of spreading very quickly makes this outbreak a dangerous pandemic. COVID-19 cases in 2020 in Indonesia, positive cases were reaching 1,089,308 people with a death rate of 20,277 people as of 2 February 2021. Efforts are being made to reduce and prevent virus transmission by boosting the immune system using an immunomodulator. Based on the literature studies that have been conducted, several Indonesian local plants have potential as immunomodulator. The in silico test was carried out because the computer simulation method has scientific validity, is relatively new, and has a high level of accuracy. This study aims to determine the protein network associated with the body's immune system, which is activated due to the administration of Brotowali (Tinospora Cordifolia). The research method used is exploratory descriptive with in silico analysis using a computational model with online databases, including KNApSAck, Dr. Duke, Pubchem, SwissADME, SwissTargetPrediction, Venny, StringDB, and KEGG. Based on the results of pharmacological network analysis, T. Cordifolia contains 33 secondary metabolites, 25 of which have high bioavailability. Proteins associated with T. cordifolia contain 640 compounds, and those related to immunomodulators contain 1380 proteins. The intersection results obtained 191 proteins predicted to interact with T. cordifolia and are related to immunomodulators. Based on KEGG Pathway analysis, there are five critical pathways in the immunomodulatory system, namely Th17 cell differentiation, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, and TNF signaling pathway. 1-hydroxy-2-methyl-anthraquinone can be an immunomodulator because it interacts with five critical pathways in the immunomodulator system.
- Open Access
- 13 November 2023
- Published by Maulana Malik Ibrahim State Islamic University in Proceedings of International Pharmacy Ulul Albab Conference and Seminar (planar)
- Vol. 3, 66-76
In Silico Potential Analysis of Acorus calamus as a Mental Depression Therapy
Depression is a common but serious mood disorder. This disease causes severe symptoms that affect one's emotions, thoughts, and daily activities, such as sleep, eating, or working. According to the National Youth Mental Health Survey of Indonesia, in 2022, 15.5 million (34.9%) teenagers suffer from mental disorders and 2.45 million (5.5%) have mental illnesses. Acorus calamus is believed to have antispasmodic, carminative, antihelmintic, aromatic, expectorant, nausea, soothing, sedative, and stimulant properties. It is also used to treat epilepsy and mental illness, chronic diarrhea, dysentery, and stomach pain. This study aims to determine the molecular mechanisms of the bioactive compound antidepressant Acorus calamus using pharmacological tissue analysis. Acorus calamus compound data obtained from Dr. Duke's database, screening of the absorption, distribution, metabolism, and excretion (ADME) of Acorus calamus Compounds with SwissADME, prediction of the Acorus calamus target compounds protein with SwissTargetpPrediction, analysis of the pharmacological network with String-DB and its visualization with Cytoscape version 3.10.1. Searching for the contents of Acorus calamus compounds resulted in 69 components and found 12 compounds that have ADME criteria that match the drug compounds (Drug Likeness/DL). The pathways correlated with therapy are the neurotransmitters of serotonin. The known target proteins are MAOA, ESR1, GRM5, CRHR1, HTR2A, DRD2, SLC6A4 and CHR with compounds that correlate with mental depression therapy, among others Aceteugenol, Acoradin, Acoramone, Alpha-Asarone, Beta-Asarone, Calamenone, Camelone, Elemicin, Isoacorone, Sekishone, trans-Isoelemicine, Epoxyisoacoragermacrone.
- 13 November 2023
- Published by Maulana Malik Ibrahim State Islamic University in Proceedings of International Pharmacy Ulul Albab Conference and Seminar (planar)
- Vol. 3, 66-76
Open AccessIn Silico Potential Analysis of Acorus calamus as a Mental Depression Therapy
Depression is a common but serious mood disorder. This disease causes severe symptoms that affect one's emotions, thoughts, and daily activities, such as sleep, eating, or working. According to the National Youth Mental Health Survey of Indonesia, in 2022, 15.5 million (34.9%) teenagers suffer from mental disorders and 2.45 million (5.5%) have mental illnesses. Acorus calamus is believed to have antispasmodic, carminative, antihelmintic, aromatic, expectorant, nausea, soothing, sedative, and stimulant properties. It is also used to treat epilepsy and mental illness, chronic diarrhea, dysentery, and stomach pain. This study aims to determine the molecular mechanisms of the bioactive compound antidepressant Acorus calamus using pharmacological tissue analysis. Acorus calamus compound data obtained from Dr. Duke's database, screening of the absorption, distribution, metabolism, and excretion (ADME) of Acorus calamus Compounds with SwissADME, prediction of the Acorus calamus target compounds protein with SwissTargetpPrediction, analysis of the pharmacological network with String-DB and its visualization with Cytoscape version 3.10.1. Searching for the contents of Acorus calamus compounds resulted in 69 components and found 12 compounds that have ADME criteria that match the drug compounds (Drug Likeness/DL). The pathways correlated with therapy are the neurotransmitters of serotonin. The known target proteins are MAOA, ESR1, GRM5, CRHR1, HTR2A, DRD2, SLC6A4 and CHR with compounds that correlate with mental depression therapy, among others Aceteugenol, Acoradin, Acoramone, Alpha-Asarone, Beta-Asarone, Calamenone, Camelone, Elemicin, Isoacorone, Sekishone, trans-Isoelemicine, Epoxyisoacoragermacrone.
- Open Access
- 13 November 2023
- Published by Maulana Malik Ibrahim State Islamic University in Proceedings of International Pharmacy Ulul Albab Conference and Seminar (planar)
- Vol. 3, 111-125
Melaleuca leucadendra Pharmacological Network for Identifying Potential Target of Alcohol Dependence
Melaleuca leucadendra (ML) contains a compound that is potentially a candidate for alcohol dependence. Alcohol dependence is defined by desire, tolerance, anxiety with alcohol, and continuing to drink even though the consequences are dangerous. The study aims to analyze the potential of the ML compound content for alcohol dependence therapy within silico-based pharmacological chain analysis. ML compound data is obtained from the Knapsack database, screening of absorption, distribution, metabolism, and excretion (ADME) of the compounds ML with SwissADME, prediction of the protein of the target compounder ML with the Swiss TargetpPrediction, Gene cards, venny, analysis of the pharmacological network with String-DB and its visualization with Cytoscape version 3.10.0. The pathways correlated with therapy are dopamine receptors, dopamine carriers, serotonin, gamma-aminobutyric acid receptors, and toll-like receptors for known therapeutic target proteins: OPRM1, DRD2, ALDH2, ADH1B, ADH1A, ADH1C, ADH4, SLC6A3, CNR1, POMC, ARRB2, and NCS1. Alcohol-dependent therapies include alpha-Campholenal, Benzaldehyde, trans-Pinocarveol, Borneol, linalool, alfa-Terpineol, (-)-alpha-Bisabolol oxide B, alphaterpine acetate, and Caryophylla-4(148),15-dien-5alphaol.
- 13 November 2023
- Published by Maulana Malik Ibrahim State Islamic University in Proceedings of International Pharmacy Ulul Albab Conference and Seminar (planar)
- Vol. 3, 111-125
Open AccessMelaleuca leucadendra Pharmacological Network for Identifying Potential Target of Alcohol Dependence
Melaleuca leucadendra (ML) contains a compound that is potentially a candidate for alcohol dependence. Alcohol dependence is defined by desire, tolerance, anxiety with alcohol, and continuing to drink even though the consequences are dangerous. The study aims to analyze the potential of the ML compound content for alcohol dependence therapy within silico-based pharmacological chain analysis. ML compound data is obtained from the Knapsack database, screening of absorption, distribution, metabolism, and excretion (ADME) of the compounds ML with SwissADME, prediction of the protein of the target compounder ML with the Swiss TargetpPrediction, Gene cards, venny, analysis of the pharmacological network with String-DB and its visualization with Cytoscape version 3.10.0. The pathways correlated with therapy are dopamine receptors, dopamine carriers, serotonin, gamma-aminobutyric acid receptors, and toll-like receptors for known therapeutic target proteins: OPRM1, DRD2, ALDH2, ADH1B, ADH1A, ADH1C, ADH4, SLC6A3, CNR1, POMC, ARRB2, and NCS1. Alcohol-dependent therapies include alpha-Campholenal, Benzaldehyde, trans-Pinocarveol, Borneol, linalool, alfa-Terpineol, (-)-alpha-Bisabolol oxide B, alphaterpine acetate, and Caryophylla-4(148),15-dien-5alphaol.